The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S,Z)-4-amino-N-(4-fluorobicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide ID: ALA4475809
PubChem CID: 137297358
Max Phase: Preclinical
Molecular Formula: C11H10FN5O2
Molecular Weight: 263.23
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nonc1/C(=N/O)N[C@H]1Cc2ccc(F)cc21
Standard InChI: InChI=1S/C11H10FN5O2/c12-6-2-1-5-3-8(7(5)4-6)14-11(15-18)9-10(13)17-19-16-9/h1-2,4,8,18H,3H2,(H2,13,17)(H,14,15)/t8-/m0/s1
Standard InChI Key: ZYPFVFRPQQRTIM-QMMMGPOBSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
33.5420 -11.5852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3591 -11.5852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6135 -10.8085 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9506 -10.3263 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.2918 -10.8085 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.8387 -12.2468 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.0608 -12.2457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2482 -12.1592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3922 -12.9926 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9110 -13.6531 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.9167 -11.4122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2114 -10.6505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1550 -11.1192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4494 -10.3604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9399 -9.7281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1359 -9.8533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8440 -10.6165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3554 -11.2456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0371 -10.7455 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
2 6 1 0
1 7 1 0
7 8 1 0
7 9 2 0
9 10 1 0
11 8 1 6
11 12 1 0
12 14 1 0
13 11 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
17 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 263.23Molecular Weight (Monoisotopic): 263.0819AlogP: 0.81#Rotatable Bonds: 2Polar Surface Area: 109.56Molecular Species: ACIDHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.31CX Basic pKa: ┄CX LogP: 0.88CX LogD: -0.22Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.32Np Likeness Score: -1.30
References 1. Zhang H, Liu K, Pu Q, Achab A, Ardolino MJ, Cheng M, Deng Y, Doty AC, Ferguson H, Fradera X, Knemeyer I, Kurukulasuriya R, Lam YH, Lesburg CA, Martinot TA, McGowan MA, Miller JR, Otte K, Biju PJ, Sciammetta N, Solban N, Yu W, Zhou H, Wang X, Bennett DJ, Han Y.. (2019) Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy., 10 (11): [PMID:31749906 ] [10.1021/acsmedchemlett.9b00344 ]